Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute

The National Institute of Health (NIH) in the United States has found that Bharat Biotech’s COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19. “Results from two studies of blood serum from people who had received suggest that the vaccine generates antibodies that effectively neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively,” NIH said in a statement.

https://www.aninews.in/news/world/us/covaxin-effectively-neutralises-both-alpha-delta-variants-of-covid-19-us-top-health-institute20210630064950/

The National Institute of Health (NIH) in the United States has found that Bharat Biotech’s COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19.

“Results from two studies of blood serum from people who had received suggest that the vaccine generates antibodies that effectively neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively,” NIH said in a statement.

Sign Up for NextBigWhat Newsletter

Daily.